All Type of News
Antibiotic prescription remarkably declined.
The Health Insurance Review Agency (HIRA) reported that the antibiotic and injectable drug prescriptions during the 1st and 2nd quarter of this year greatly declined by 19.0% and 14.2% respectively compared to the sam...
KPA to receive reports on poor quality drugs in large packages.
The Korea Pharmaceutical Association (KPA) actively asked for all member pharmacies to report any incidences related with bad quality of drugs in large packages.
The Illicit and Bad Quality Drug Report Center (here...
Medical circle to publicize selective system of separating drug dispensing from medical practice
The Korea Doctors Association argued that the current system of separating drug dispensing from medical practice (SDP), which has proven to be in total failure, should be swifted to the selective SDP system that is mo...
Lilly Korea is willingness to compensate wholesalers over pricing reduction portion of Zyprexa...
Lilly Korea is willingness to compensate wholesalers over pricing reduction portion of Zyprexa tablet
Lilly Korea said on December 2 that it is willing to fully compensate the pricing reduction portion of domestic ...
Novartis Korea named Peter Maag as new president
Novartis Korea announced recently the appointment of Dr. Peter Maag as a new president and Dr. Frank Bobe, who was a former president for the Korean unit for three and half years, has become vice president of Novartis...
Company value to maximize with brand image.
"Brand is a competitiveness" becomes an axiom in the business arena these days, which seems to be quite true in the pharmaceutical companies. In the recent commercial advertising contest, quite a number of drug advert...
Pharmacists to claim due compensation for Zyprexa business loss.
The government reduced the NHI prices of Zyprexa (Olanzapine: anti-psychotic drug) by 14 to 39.9% as of Dec. 1 after its prescription being reclassified from a drug of the 2nd choice to of the first choice, which even...
Seoul Medical Association to protest against NHI pricing policy
Amid a harsh backlash over the government's NHI reimbursement price increase merely at 2.65% in 2004 from this year, Seoul Medical Association decided to have a group rally on Dec. 27 to demonstrate its official posit...
Biopharmaceutical firms grapping with recruitment of talented people
In sharp contrast with today's drying-up job market in young people, biopharmaceutical firms have faced serious shortage of talented human resources with proper professional knowledge.
Business sources say that tal...
KPA to demand compensation of Zyprexa tablet
Following the price cut of Lilly Korea's Zyprexa (olanzapine) tablet by 14 to 39.9 percent from December 1st in line with its re-designation as the first-line drug in treatment of psychosis, the Korea Pharmaceutical A...
